Trends in antifungal use characteristics in primary care in Spain, 2019 to 2024: a nationwide study
Revista Española de Quimioterapia · 29.05.2026 · 39 (3) · 253
DOI: 10.37201/req/173.2026 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 29.05.2026. Verfasst von Álvaro Solaz-García und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitari i Politècnic La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Antifungal Agents, Primary Health Care, Drug Utilization. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Antifungal resistance is a growing global concern in the context of antimicrobial resistance. Although primary care is the main setting for managing superficial fungal infections, national evidence on antifungal consumption in Spain remains limited. This study analyzes the characteristics of antifungal use in Spanish primary care.
Methods
A retrospective observational study was conducted using data from the Primary Care Clinical Database of the Spanish Ministry of Health. The study included individuals assigned to primary care with at least one antifungal dispensation per year between 2019-2024. Consumption was measured as Defined Daily Doses (DDD) per 1,000 inhabitants per day (DHD), following the WHO ATC/DDD methodology. Trends were analyzed by sex, age, municipality size, income level, country of birth, and employment status, using annual percentage change (APC) estimated through joinpoint regression models.
Results
From 2019 to 2024, antifungal DHD in Spanish primary care increased significantly overall (APC: 8.4% [6.2-10.5]; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Research Group in Perinatology, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
- Research Group in Nursing and Health Care, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Majadahonda, Madrid, Spain.
- Scientific Area, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain.
- Translational Research on Emerging Pathogens, Microorganisms and Public Health, Severe Infection Research Group, Health Research Institute Hospital La Fe (IIS La Fe), Valencia, Spain. alba.ruiz@ext.uv.es.
ORCID-Profile: Álvaro Solaz-García, Héctor Sánchez-Herrero, Nerea Valles-Murcia, María José Soriano-Ortega, Alba Ruiz-Gaitán
Zitieren
APA
Solaz-García, Á., Sánchez-Herrero, H., Valles-Murcia, N., Soriano-Ortega, M. J., & Ruiz-Gaitán, A. (2026). Trends in antifungal use characteristics in primary care in Spain, 2019 to 2024: a nationwide study. Revista Española de Quimioterapia, 39(3), 253. https://doi.org/10.37201/req/173.2026
Vancouver
Solaz-García Á, Sánchez-Herrero H, Valles-Murcia N, Soriano-Ortega MJ, Ruiz-Gaitán A. Trends in antifungal use characteristics in primary care in Spain, 2019 to 2024: a nationwide study. Revista Española de Quimioterapia. 2026;39(3):253. doi:10.37201/req/173.2026
BibTeX
@article{SolazGarca2026,
author = {Solaz-García, Álvaro and Sánchez-Herrero, Héctor and Valles-Murcia, Nerea and Soriano-Ortega, María José and Ruiz-Gaitán, Alba},
title = {Trends in antifungal use characteristics in primary care in Spain, 2019 to 2024: a nationwide study},
journal = {Revista Española de Quimioterapia},
year = {2026},
volume = {39},
number = {3},
pages = {253},
doi = {10.37201/req/173.2026}
}
EUVIMED